Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Clinical trial NCT01421004 · COMPLETED
Trial details
- NCT number
- NCT01421004
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-07-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.